D. E. Shaw & Co., Inc. Ars Pharmaceuticals, Inc. Comm Transaction History
D. E. Shaw & Co., Inc.
- $107 Billion
- Q3 2024
A detailed history of D. E. Shaw & Co., Inc. transactions in Ars Pharmaceuticals, Inc. Comm stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 80,548 shares of SPRY stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
80,548Holding current value
$0% of portfolio
0.0%Shares
12 transactions